suloctidil and Intracranial-Arteriosclerosis

suloctidil has been researched along with Intracranial-Arteriosclerosis* in 3 studies

Trials

1 trial(s) available for suloctidil and Intracranial-Arteriosclerosis

Article	Year
[Therapeutic use of a new vasoactive drug in cerebral vascular diseases in elderly patients]. La Clinica terapeutica, 1980, Aug-31, Volume: 94, Issue:4 Topics: Aged; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Intracranial Arteriosclerosis; Male; Middle Aged; Propanolamines; Suloctidil; Vinca Alkaloids; Vincamine	1980

Other Studies

2 other study(ies) available for suloctidil and Intracranial-Arteriosclerosis

Article	Year
[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability]. La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3 Red blood cell filtration, platelet aggregation, serum triglyceride and cholesterol levels were investigated in 15 patients with chronic cerebrovascular disease, 10 of whom treated with Suloctidil and 5 with pentoxifylline. The treatment was carried out in 90 days. Both pentoxifylline and Suloctidil produced a significant improvement of erythrocyte deformability and a decrease of platelet aggregation. Topics: Cholesterol; Chronic Disease; Erythrocytes; Humans; Intracranial Arteriosclerosis; Pentoxifylline; Platelet Aggregation; Propanolamines; Suloctidil; Theobromine; Triglycerides	1983
[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil]. La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3 In 17 patients affected by atherosclerotic vascular disease and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil. At the end of treatment carried out for 5 months the results showed that erythrocyte filterability was the only hemorheological determinant influenced. The possible causes of this action are therefore considered. Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle Aged; Propanolamines; Rheology; Suloctidil	1983

Article

Year

[Chronic senile cerebrovascular insufficiency. Effects of suloctidil and pentoxifylline on erythrocyte deformability].

La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

Red blood cell filtration, platelet aggregation, serum triglyceride and cholesterol levels were investigated in 15 patients with chronic cerebrovascular disease, 10 of whom treated with Suloctidil and 5 with pentoxifylline. The treatment was carried out in 90 days. Both pentoxifylline and Suloctidil produced a significant improvement of erythrocyte deformability and a decrease of platelet aggregation.

Topics: Cholesterol; Chronic Disease; Erythrocytes; Humans; Intracranial Arteriosclerosis; Pentoxifylline; Platelet Aggregation; Propanolamines; Suloctidil; Theobromine; Triglycerides

1983

[Hemorrheological survey in a group with arteriosclerotic vascular disease treated with suloctidil].

La Ricerca in clinica e in laboratorio, 1983, Volume: 13 Suppl 3

In 17 patients affected by atherosclerotic vascular disease and showing in basal conditions a hyperviscosity state, we have monitored the main hemorheological determinants during treatment with Suloctidil. At the end of treatment carried out for 5 months the results showed that erythrocyte filterability was the only hemorheological determinant influenced. The possible causes of this action are therefore considered.

Topics: Aged; Arterial Occlusive Diseases; Blood Viscosity; Erythrocytes; Female; Fibrinogen; Hematocrit; Humans; Intracranial Arteriosclerosis; Leg; Male; Middle Aged; Propanolamines; Rheology; Suloctidil

1983